Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study

BACKGROUND: In October 2017, the United Kingdom Joint Committee on Vaccination and Immunisation (JCVI) recommended removal of one primary dose of the 13-valent pneumococcal conjugate vaccine (PCV13) from the existing 2+1 schedule (2, 4, 12 months). We conducted a mathematical modelling study to inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yoon Hong, Andrews, Nick, Miller, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6608946/
https://www.ncbi.nlm.nih.gov/pubmed/31269018
http://dx.doi.org/10.1371/journal.pmed.1002845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6608946/
https://www.ncbi.nlm.nih.gov/pubmed/31269018
http://dx.doi.org/10.1371/journal.pmed.1002845

Ejemplares similares